Using stem cells to generate new neurons and replace those lost in diseases such as Parkinson and amyotrophic lateral sclerosis would be a major breakthrough, but significant hurdles remain before this goal can be realized. Instead, a more practical short-term approach may be to use stem cells to protect neurons dying in these diseases.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies
Acta Neuropathologica Open Access 27 November 2018
-
Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives
Neurotherapeutics Open Access 09 September 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tai, Y.-T. & Svendsen, C.N. Curr. Opin. Pharmacol. 4, 98–104 (2004).
Thomson, J.A. et al. Science 282, 1145–1147 (1998).
Bjorklund, L.M. et al. Proc. Natl. Acad. Sci. USA 99, 2344–2347 (2002).
Kim, J.H. et al. Nature 418, 50–56 (2002).
Kerr, D.A. et al. J. Neurosci. 23, 5131–5140 (2003).
Wichterle, H., Lieberam, I., Porter, J.A. & Jessell, T.M. Cell 110, 385–397 (2002).
Doetsch, F., Caille, I., Lim, D.A., Garcia-Verdugo, J.M. & Alvarez-Buylla, A. Cell 97, 703–716 (1999).
Imura, T., Kornblum, H.I. & Sofroniew, M.V. J. Neurosci. 23, 2824–2832 (2003).
Gill, S.S. et al. Nat. Med. 9, 589–595 (2003).
Ourednik, J., Ourednik, V., Lynch, W.P., Schachner, M. & Snyder, E.Y. Nat. Biotechnol. 20, 1103–1110 (2002).
Clement, A.M. Science 302, 113–117 (2003).
Olanow, C.W. et al. Ann. Neurol. 54, 403–414 (2003).
Acknowledgements
We would like to thank the NETRP program at the DOD for supporting this meeting, and the presenters (J. Thomson, S.C. Zhang, J. Rothstein, M. Sofroniew, M. Bohn, A. Blesch, E. Snyder, R. Brown and S. Landis) for their stimulating discussion and comments on this article.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Svendsen, C., Langston, J. Stem cells for Parkinson disease and ALS: replacement or protection?. Nat Med 10, 224–225 (2004). https://doi.org/10.1038/nm0304-224
Issue Date:
DOI: https://doi.org/10.1038/nm0304-224
This article is cited by
-
Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies
Acta Neuropathologica (2019)
-
Comparative Effects between Bone Marrow and Mesenchymal Stem Cell Transplantation in GDNF Expression and Motor Function Recovery in a Motorneuron Degenerative Mouse Model
Stem Cell Reviews and Reports (2012)
-
Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives
Neurotherapeutics (2011)
-
Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice
Gene Therapy (2009)
-
Proof of delivery
Nature Reviews Genetics (2006)